Yesterdays' announced financings: April 4

Here’s your roundup of yesterday's announced financings, courtesy of PrivatePlacements.com: the only database that tracks every financing, every day.

1. C3 Metals Inc. (TSX-V: CCCM)

• Gross Proceeds: $5 million
• Sector: Precious metals
• Units issued: 100 million
• Type: Common shares
• Price: $0.05
• Warrants: None
• Agents: Non-brokered
• Use of Proceeds: Working capital

Company breakdown:

• Gold and copper junior with projects in Peru and Jamaica
• Maiden resource estimate for its Jasperoide project is expected in Q2 2023
• Drilled 12.9 metres of 0.24% copper at its Arthurs Seat project in late March

2. Clearmind Medicine Inc. (CSE: CMND)

• Gross Proceeds: US$3.5 million
• Sector: Psychedelics
• Units issued: 4.5 million
• Type: Special units
• Price: US$0.78
• Warrants: Full; US$0.78; Five years
• Agents: Aegis Capital Corp.
• Use of Proceeds: Working capital

Company breakdown:

• Psychedelics company that aims to develop new medicines
• Aims to use MEAI to cure alcohol use disorder

3. Kodiak Copper Corp. (TSX-V: KDK)

• Gross Proceeds: $6.5 million
• Sector: Copper
• Units issued: 1.5 million; 3.7 million; 833,333; 418,498
• Type: Flow-through units; Special units; Flow-through units; Special units
• Price: $1.32; $0.81
• Warrants: Half; $1.10; Two years
• Agents: Cormark Securities Inc.; Non-brokered
• Use of Proceeds: Working capital

Company breakdown:

• Gold and copper junior with projects in B.C. and Arizona
• Announced it has moved its staff to its MPD project in B.C. for exploration
• 25,000 metres of drilling is planned for 2023

4. ChitogenX Inc. (CSE: CHGX)

• Gross Proceeds: $2.5 million
• Sector: Biotech
• Units issued: 12.5 million
• Type: Special units
• Price: $0.20
• Warrants: Full; $0.35; Five years
• Agents: Non-brokered
• Use of Proceeds: Clinical trials

Company breakdown:

• Biotech company that aims to use regenerative medicine to repair rotator cuff and meniscus injuries
• Proceeds from the offering will be used for its rotator cuff tear repair phase I and II clinical trial program

5. Koios Beverage Corp. (CSE: FIT)

• Gross Proceeds: $1.67 million
• Sector: Supplements
• Units issued: 33.45 million
• Type: Special units
• Price: $0.05
• Warrants: Full; $0.05; Two years
• Agents: Non-brokered
• Use of Proceeds: Purchases

Company breakdown:

• Company that creates brain supplement drinks
• Shares plummeted in May 2022